(Q48422656)

English

Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes

scientific article published in February 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

Alzheimer's disease

0 references

type 2 diabetes

0 references

author name string

Weijie Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

Yan Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

Gang Yuan

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

Wenjun Zhu

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

Delin Ma

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

Shuhong Hu

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

publication date

1 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

Journal of Investigative Medicine

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

63

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

267-272

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

The development of effective biomarkers for Alzheimer's disease: a review

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Tau protein kinases: involvement in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Insulin in central nervous system: more than just a peripheral hormone

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Linking type 2 diabetes and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Memory function and brain glucose metabolism

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Biphasic effects of stress upon GLUT8 glucose transporter expression and trafficking in the diabetic rat hippocampus

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Mechanism-based population modelling for assessment of L-cell function based on total GLP-1 response following an oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system.

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Glucagon like peptide-1-directed human embryonic stem cells differentiation into insulin-producing cells via hedgehog, cAMP, and PI3K pathways

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Detection of beta-endorphin in the cerebrospinal fluid after intrastriatal microinjection into the rat brain

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Mechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Current and emerging drug treatment options for Alzheimer's disease: a systematic review.

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Targeting tau protein in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000129

21 January 2018

Identifiers

10.1097/JIM.0000000000000129

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25479064

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48422656&oldid=2198438882"